CIK 0001736730 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Camp4 Therapeutics Corp
Sign in to watch- Ticker
- CAMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-651-8867
- Business address
- 100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $3.96 ($39,600)
- 4 Open-market sale Director sold 400,000 shares at $4.04 ($1,616,000)
- 4 Open-market sale Director sold 10 shares at $4.50 ($45)
- 4 Open-market sale Director sold 191,865 shares at an average $4.59 ($879,719)
- 4 Open-market sale Chief Scientific Officer sold 1,738 shares at $4.76 ($8,273)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 16,378 shares at $1.65 ($27,024)
- 4 Open-market buy Chief Medical Officer bought 6,551 shares at $1.65 ($10,809)
- 4 Open-market buy Chief Financial Officer bought 6,551 shares at $1.65 ($10,809)
- 4 Open-market buy Chief Executive Officer bought 6,551 shares at $1.65 ($10,809)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 5 · 84 filings